Download Files:
Recilisib
$110 – $750
Products Details
Product Description
– Recilisib (ON 01210) is a radioprotectant, which can activate AKT, PI3K activities in cells[1].
Web ID
– HY-101625
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C16H13ClO4S
References
– [1]Kang AD, et al. ON01210.Na (Ex-RAD) mitigates radiation damage through activation of the AKT pathway. PLoS One. 2013;8(3):e58355.
CAS Number
– 334969-03-8
Molecular Weight
– 336.79
Compound Purity
– 99.14
SMILES
– O=C(O)C1=CC=C(/C=C/S(=O)(CC2=CC=C(Cl)C=C2)=O)C=C1
Clinical Information
– Phase 1
Research Area
– Cancer
Solubility
– DMSO : 35.71 mg/mL (ultrasonic)
Target
– Akt;PI3K
Isoform
– PI3K
Pathway
– PI3K/Akt/mTOR
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
